

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.91628357 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.85039748 |
| 3 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.85039748 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.58132133 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.16916135 |
| 6 | neutrophil activation involved in immune response (GO:0002283) | 4.16773361 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.12338409 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.07360058 |
| 9 | immunoglobulin mediated immune response (GO:0016064) | 4.05905686 |
| 10 | NIK/NF-kappaB signaling (GO:0038061) | 3.97003814 |
| 11 | positive regulation by symbiont of host defense response (GO:0052509) | 3.92954270 |
| 12 | modulation by symbiont of host defense response (GO:0052031) | 3.92954270 |
| 13 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.92954270 |
| 14 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.92954270 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.92954270 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.92954270 |
| 17 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.90697934 |
| 18 | positive regulation of humoral immune response (GO:0002922) | 3.76628848 |
| 19 | response to peptidoglycan (GO:0032494) | 3.64876324 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 3.61877208 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 3.57316288 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.52818782 |
| 23 | positive regulation of isotype switching (GO:0045830) | 3.46708704 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 3.42437211 |
| 25 | detection of other organism (GO:0098543) | 3.36849272 |
| 26 | type I interferon signaling pathway (GO:0060337) | 3.31420018 |
| 27 | cellular response to type I interferon (GO:0071357) | 3.31420018 |
| 28 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30396534 |
| 29 | detection of bacterium (GO:0016045) | 3.29025274 |
| 30 | response to type I interferon (GO:0034340) | 3.25737180 |
| 31 | B cell mediated immunity (GO:0019724) | 3.25702873 |
| 32 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.24754655 |
| 33 | B cell receptor signaling pathway (GO:0050853) | 3.15804540 |
| 34 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.11007889 |
| 35 | neutrophil activation (GO:0042119) | 3.10030756 |
| 36 | granulocyte activation (GO:0036230) | 3.08574548 |
| 37 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.07227195 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.03513227 |
| 39 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.03371559 |
| 40 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.01692238 |
| 41 | T cell migration (GO:0072678) | 3.00760983 |
| 42 | negative regulation of T cell mediated immunity (GO:0002710) | 2.98623712 |
| 43 | positive regulation of B cell mediated immunity (GO:0002714) | 2.97627365 |
| 44 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.97627365 |
| 45 | positive regulation of DNA recombination (GO:0045911) | 2.96106160 |
| 46 | piRNA metabolic process (GO:0034587) | 2.93961559 |
| 47 | negative thymic T cell selection (GO:0045060) | 2.93148770 |
| 48 | defense response to protozoan (GO:0042832) | 2.92536146 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.91354318 |
| 50 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.91216253 |
| 51 | regulation of mast cell degranulation (GO:0043304) | 2.91051931 |
| 52 | leukocyte aggregation (GO:0070486) | 2.88743158 |
| 53 | T-helper 1 type immune response (GO:0042088) | 2.88233729 |
| 54 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.88207193 |
| 55 | cellular extravasation (GO:0045123) | 2.87611789 |
| 56 | positive regulation of mast cell activation (GO:0033005) | 2.84557163 |
| 57 | response to protozoan (GO:0001562) | 2.83000391 |
| 58 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.81713902 |
| 59 | negative T cell selection (GO:0043383) | 2.79373053 |
| 60 | response to muramyl dipeptide (GO:0032495) | 2.78407617 |
| 61 | positive regulation of B cell differentiation (GO:0045579) | 2.78347608 |
| 62 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.74358911 |
| 63 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.74358911 |
| 64 | detection of external biotic stimulus (GO:0098581) | 2.74270491 |
| 65 | negative regulation of innate immune response (GO:0045824) | 2.73742123 |
| 66 | response to interleukin-15 (GO:0070672) | 2.73549226 |
| 67 | cellular response to interleukin-15 (GO:0071350) | 2.72598984 |
| 68 | microglial cell activation (GO:0001774) | 2.71720478 |
| 69 | regulation of B cell differentiation (GO:0045577) | 2.71569871 |
| 70 | regulation of T cell tolerance induction (GO:0002664) | 2.71267441 |
| 71 | leukocyte degranulation (GO:0043299) | 2.69168103 |
| 72 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.69128700 |
| 73 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.68906027 |
| 74 | positive regulation of interferon-beta production (GO:0032728) | 2.68357089 |
| 75 | regulation of interferon-alpha production (GO:0032647) | 2.67153248 |
| 76 | tolerance induction (GO:0002507) | 2.66154538 |
| 77 | positive regulation of type 2 immune response (GO:0002830) | 2.65955976 |
| 78 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.65946267 |
| 79 | positive regulation of interferon-alpha production (GO:0032727) | 2.65526793 |
| 80 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62593818 |
| 81 | response to host immune response (GO:0052572) | 2.62593818 |
| 82 | respiratory burst (GO:0045730) | 2.61399460 |
| 83 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.60903001 |
| 84 | regulation of isotype switching (GO:0045191) | 2.59212335 |
| 85 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.56443259 |
| 86 | positive regulation of interleukin-17 production (GO:0032740) | 2.55144441 |
| 87 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54884017 |
| 88 | interferon-gamma production (GO:0032609) | 2.54871930 |
| 89 | macrophage activation (GO:0042116) | 2.54732454 |
| 90 | regulation of mast cell activation (GO:0033003) | 2.53500505 |
| 91 | myeloid dendritic cell differentiation (GO:0043011) | 2.53040646 |
| 92 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.52666289 |
| 93 | positive regulation of antigen processing and presentation (GO:0002579) | 2.52661209 |
| 94 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52586772 |
| 95 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.52196779 |
| 96 | positive thymic T cell selection (GO:0045059) | 2.52019239 |
| 97 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.51571932 |
| 98 | detection of molecule of bacterial origin (GO:0032490) | 2.50123770 |
| 99 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.49598569 |
| 100 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.48680749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.75794506 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.30556877 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.19940935 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.97541921 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.72897871 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.62323806 |
| 7 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.19876373 |
| 8 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.14928687 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.03092984 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.85245559 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.81534662 |
| 12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.76998444 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.75646868 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.73176378 |
| 15 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70440754 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.56331881 |
| 17 | MYB_26560356_Chip-Seq_TH2_Human | 2.47456162 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46464657 |
| 19 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 2.45329113 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26076651 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.25399674 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.16059494 |
| 23 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.08593483 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.05968198 |
| 25 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.04685715 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.03531973 |
| 27 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.02956139 |
| 28 | MYB_26560356_Chip-Seq_TH1_Human | 2.02951266 |
| 29 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.98519389 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.97451585 |
| 31 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96664636 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.96066682 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.93107135 |
| 34 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89566038 |
| 35 | UTX_26944678_Chip-Seq_JUKART_Human | 1.88468392 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.88013804 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.87512969 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.79953451 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75715715 |
| 40 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75464253 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.69041989 |
| 42 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65083632 |
| 43 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.64820567 |
| 44 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.64697741 |
| 45 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.58316144 |
| 46 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.55599615 |
| 47 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.54260598 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.50911785 |
| 49 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49507688 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.48879750 |
| 51 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.48272434 |
| 52 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.47440690 |
| 53 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.47300239 |
| 54 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41658747 |
| 55 | MAF_26560356_Chip-Seq_TH2_Human | 1.41474935 |
| 56 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41391636 |
| 57 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40967611 |
| 58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34626627 |
| 59 | GATA3_26560356_Chip-Seq_TH2_Human | 1.33658169 |
| 60 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.33470747 |
| 61 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33047206 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27594027 |
| 63 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26235457 |
| 64 | GATA1_19941826_ChIP-Seq_K562_Human | 1.21873471 |
| 65 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19634863 |
| 66 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16728171 |
| 67 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15803879 |
| 68 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14455551 |
| 69 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.13307902 |
| 70 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.12000448 |
| 71 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.11033089 |
| 72 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.10645786 |
| 73 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09810905 |
| 74 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.08169885 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.08041545 |
| 76 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.07329203 |
| 77 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06497576 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.05719278 |
| 79 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04424496 |
| 80 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04105226 |
| 81 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.04003273 |
| 82 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03035869 |
| 83 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.01560383 |
| 84 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98303906 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97250190 |
| 86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.96654384 |
| 87 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95907410 |
| 88 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.94927396 |
| 89 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.94643873 |
| 90 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94432994 |
| 91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.94130272 |
| 92 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93565993 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91111384 |
| 94 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89048489 |
| 95 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.88320509 |
| 96 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88074685 |
| 97 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87952323 |
| 98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87732634 |
| 99 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.85644006 |
| 100 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84269128 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.34686689 |
| 2 | MP0003303_peritoneal_inflammation | 3.33250338 |
| 3 | MP0003436_decreased_susceptibility_to | 3.31536972 |
| 4 | MP0006082_CNS_inflammation | 3.11081901 |
| 5 | MP0005671_abnormal_response_to | 2.99725915 |
| 6 | MP0003724_increased_susceptibility_to | 2.90990785 |
| 7 | MP0000685_abnormal_immune_system | 2.79170767 |
| 8 | MP0005000_abnormal_immune_tolerance | 2.77991737 |
| 9 | MP0009785_altered_susceptibility_to | 2.77260554 |
| 10 | MP0005387_immune_system_phenotype | 2.74010689 |
| 11 | MP0001790_abnormal_immune_system | 2.74010689 |
| 12 | MP0001800_abnormal_humoral_immune | 2.69331966 |
| 13 | MP0009840_abnormal_foam_cell | 2.55785814 |
| 14 | MP0002723_abnormal_immune_serum | 2.44928505 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.44923651 |
| 16 | MP0005451_abnormal_body_composition | 2.44505144 |
| 17 | MP0002419_abnormal_innate_immunity | 2.40908920 |
| 18 | MP0005464_abnormal_platelet_physiology | 2.39084045 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.36028037 |
| 20 | MP0005025_abnormal_response_to | 2.35625270 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.30446887 |
| 22 | MP0002420_abnormal_adaptive_immunity | 2.25505487 |
| 23 | MP0001819_abnormal_immune_cell | 2.21889616 |
| 24 | MP0003300_gastrointestinal_ulcer | 2.21393483 |
| 25 | MP0009333_abnormal_splenocyte_physiolog | 2.11384566 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 2.00730002 |
| 27 | MP0002398_abnormal_bone_marrow | 1.99321248 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.97723399 |
| 29 | MP0002405_respiratory_system_inflammati | 1.96571738 |
| 30 | MP0008260_abnormal_autophagy | 1.95436638 |
| 31 | MP0010155_abnormal_intestine_physiology | 1.87574445 |
| 32 | MP0000716_abnormal_immune_system | 1.82840822 |
| 33 | MP0005310_abnormal_salivary_gland | 1.82834676 |
| 34 | MP0002139_abnormal_hepatobiliary_system | 1.78744544 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.75108363 |
| 36 | MP0001845_abnormal_inflammatory_respons | 1.70445412 |
| 37 | MP0004947_skin_inflammation | 1.68797552 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.64569726 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.62455139 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.62241123 |
| 41 | MP0002722_abnormal_immune_system | 1.57455182 |
| 42 | MP0005058_abnormal_lysosome_morphology | 1.56168168 |
| 43 | MP0009764_decreased_sensitivity_to | 1.51001727 |
| 44 | MP0002429_abnormal_blood_cell | 1.49698475 |
| 45 | MP0002132_abnormal_respiratory_system | 1.48097959 |
| 46 | MP0005397_hematopoietic_system_phenotyp | 1.46884887 |
| 47 | MP0001545_abnormal_hematopoietic_system | 1.46884887 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.43739028 |
| 49 | MP0008469_abnormal_protein_level | 1.42379620 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.40493141 |
| 51 | MP0001873_stomach_inflammation | 1.38619508 |
| 52 | MP0009278_abnormal_bone_marrow | 1.37486584 |
| 53 | MP0000703_abnormal_thymus_morphology | 1.36001477 |
| 54 | MP0003718_maternal_effect | 1.33967734 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.28798505 |
| 56 | MP0003866_abnormal_defecation | 1.24025420 |
| 57 | MP0008004_abnormal_stomach_pH | 1.08532251 |
| 58 | MP0000858_altered_metastatic_potential | 1.06890062 |
| 59 | MP0004510_myositis | 1.01706543 |
| 60 | MP0002998_abnormal_bone_remodeling | 1.01650231 |
| 61 | MP0000343_altered_response_to | 1.01124072 |
| 62 | MP0004808_abnormal_hematopoietic_stem | 1.00265198 |
| 63 | MP0000604_amyloidosis | 0.94511130 |
| 64 | MP0009763_increased_sensitivity_to | 0.94013861 |
| 65 | MP0001851_eye_inflammation | 0.93204630 |
| 66 | MP0000490_abnormal_crypts_of | 0.92681259 |
| 67 | MP0005166_decreased_susceptibility_to | 0.90406070 |
| 68 | MP0001853_heart_inflammation | 0.90293141 |
| 69 | MP0009765_abnormal_xenobiotic_induced | 0.89444065 |
| 70 | MP0003828_pulmonary_edema | 0.86214393 |
| 71 | MP0003690_abnormal_glial_cell | 0.81448544 |
| 72 | MP0003221_abnormal_cardiomyocyte_apopto | 0.79220471 |
| 73 | MP0002332_abnormal_exercise_endurance | 0.78921709 |
| 74 | MP0005360_urolithiasis | 0.76948392 |
| 75 | MP0005075_abnormal_melanosome_morpholog | 0.74779108 |
| 76 | MP0002166_altered_tumor_susceptibility | 0.73984223 |
| 77 | MP0000609_abnormal_liver_physiology | 0.73635132 |
| 78 | MP0001663_abnormal_digestive_system | 0.73038793 |
| 79 | MP0008874_decreased_physiological_sensi | 0.72711770 |
| 80 | MP0003075_altered_response_to | 0.70284563 |
| 81 | MP0003252_abnormal_bile_duct | 0.68441778 |
| 82 | MP0002396_abnormal_hematopoietic_system | 0.67986629 |
| 83 | MP0002019_abnormal_tumor_incidence | 0.67962899 |
| 84 | MP0005410_abnormal_fertilization | 0.67381372 |
| 85 | MP0003448_altered_tumor_morphology | 0.66782455 |
| 86 | MP0004381_abnormal_hair_follicle | 0.66530272 |
| 87 | MP0005319_abnormal_enzyme/_coenzyme | 0.65318277 |
| 88 | MP0003879_abnormal_hair_cell | 0.64946229 |
| 89 | MP0003806_abnormal_nucleotide_metabolis | 0.63953039 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.61592809 |
| 91 | MP0003950_abnormal_plasma_membrane | 0.60767535 |
| 92 | MP0003329_amyloid_beta_deposits | 0.60236464 |
| 93 | MP0002006_tumorigenesis | 0.58473113 |
| 94 | MP0005164_abnormal_response_to | 0.57550706 |
| 95 | MP0005085_abnormal_gallbladder_physiolo | 0.57181561 |
| 96 | MP0008961_abnormal_basal_metabolism | 0.55791234 |
| 97 | MP0005395_other_phenotype | 0.54652655 |
| 98 | MP0002163_abnormal_gland_morphology | 0.54366020 |
| 99 | MP0002277_abnormal_respiratory_mucosa | 0.53626481 |
| 100 | MP0003795_abnormal_bone_structure | 0.52925302 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 4.85439799 |
| 2 | Stomatitis (HP:0010280) | 4.28557247 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.07476027 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.05411518 |
| 5 | Recurrent abscess formation (HP:0002722) | 3.93219062 |
| 6 | Increased IgM level (HP:0003496) | 3.91741376 |
| 7 | Myositis (HP:0100614) | 3.80971900 |
| 8 | Recurrent fungal infections (HP:0002841) | 3.77001402 |
| 9 | Recurrent cutaneous fungal infections (HP:0011370) | 3.74686867 |
| 10 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.74686867 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72223735 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 3.71950451 |
| 13 | Optic neuritis (HP:0100653) | 3.71950451 |
| 14 | Orchitis (HP:0100796) | 3.63606563 |
| 15 | Loss of speech (HP:0002371) | 3.63218122 |
| 16 | Abnormality of T cell number (HP:0011839) | 3.52557337 |
| 17 | T lymphocytopenia (HP:0005403) | 3.51149315 |
| 18 | Vasculitis (HP:0002633) | 3.39267977 |
| 19 | Recurrent skin infections (HP:0001581) | 3.21701075 |
| 20 | Recurrent viral infections (HP:0004429) | 3.20165622 |
| 21 | Meningitis (HP:0001287) | 3.17724407 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.14355377 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.12985731 |
| 24 | Encephalitis (HP:0002383) | 3.12221905 |
| 25 | Autoimmune thrombocytopenia (HP:0001973) | 3.08667699 |
| 26 | Agammaglobulinemia (HP:0004432) | 3.07333645 |
| 27 | Abnormality of T cells (HP:0002843) | 2.95831917 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 2.91789531 |
| 29 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.88006640 |
| 30 | Prolonged bleeding time (HP:0003010) | 2.87719866 |
| 31 | Obstructive lung disease (HP:0006536) | 2.83247375 |
| 32 | Chronic obstructive pulmonary disease (HP:0006510) | 2.83247375 |
| 33 | Gastrointestinal stroma tumor (HP:0100723) | 2.78521334 |
| 34 | Gastrointestinal infarctions (HP:0005244) | 2.77478441 |
| 35 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.74511684 |
| 36 | Petechiae (HP:0000967) | 2.72096589 |
| 37 | Gingival bleeding (HP:0000225) | 2.70816669 |
| 38 | Keratoconjunctivitis (HP:0001096) | 2.68756920 |
| 39 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.66293749 |
| 40 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.66293749 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.66293749 |
| 42 | Urticaria (HP:0001025) | 2.65433581 |
| 43 | Pulmonary infiltrates (HP:0002113) | 2.61241603 |
| 44 | Chronic diarrhea (HP:0002028) | 2.59506910 |
| 45 | Lymphopenia (HP:0001888) | 2.58579054 |
| 46 | Leukocytosis (HP:0001974) | 2.58103080 |
| 47 | Epistaxis (HP:0000421) | 2.56286570 |
| 48 | Abnormality of T cell physiology (HP:0011840) | 2.55427710 |
| 49 | Panhypogammaglobulinemia (HP:0003139) | 2.55233511 |
| 50 | Pustule (HP:0200039) | 2.53424098 |
| 51 | Granulocytopenia (HP:0001913) | 2.52922632 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.50300014 |
| 53 | Inflammation of the large intestine (HP:0002037) | 2.49559298 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.47093244 |
| 55 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.43250166 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.38656647 |
| 57 | Gastrointestinal inflammation (HP:0004386) | 2.37692949 |
| 58 | Purpura (HP:0000979) | 2.37607081 |
| 59 | Abnormality of B cell number (HP:0010975) | 2.35110724 |
| 60 | Increased IgE level (HP:0003212) | 2.32890382 |
| 61 | Osteomyelitis (HP:0002754) | 2.32761806 |
| 62 | Acute hepatic failure (HP:0006554) | 2.31713309 |
| 63 | Eosinophilia (HP:0001880) | 2.29345172 |
| 64 | Generalized aminoaciduria (HP:0002909) | 2.28761679 |
| 65 | Spontaneous hematomas (HP:0007420) | 2.26774678 |
| 66 | Vacuolated lymphocytes (HP:0001922) | 2.23612514 |
| 67 | Fatigue (HP:0012378) | 2.23507274 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 2.23005749 |
| 69 | Male infertility (HP:0003251) | 2.22183394 |
| 70 | Cellulitis (HP:0100658) | 2.21983403 |
| 71 | Anorexia (HP:0002039) | 2.21009476 |
| 72 | Chest pain (HP:0100749) | 2.20631617 |
| 73 | Severe combined immunodeficiency (HP:0004430) | 2.20361623 |
| 74 | Combined immunodeficiency (HP:0005387) | 2.19625832 |
| 75 | Abnormal gallbladder physiology (HP:0012438) | 2.19591436 |
| 76 | Cholecystitis (HP:0001082) | 2.19591436 |
| 77 | Joint swelling (HP:0001386) | 2.19561499 |
| 78 | Prolonged neonatal jaundice (HP:0006579) | 2.17865519 |
| 79 | Increased serum ferritin (HP:0003281) | 2.15139314 |
| 80 | Abnormality of eosinophils (HP:0001879) | 2.12958580 |
| 81 | Hemoptysis (HP:0002105) | 2.12698488 |
| 82 | Episodic fever (HP:0001954) | 2.10707817 |
| 83 | IgG deficiency (HP:0004315) | 2.10219924 |
| 84 | Colitis (HP:0002583) | 2.09968289 |
| 85 | Gangrene (HP:0100758) | 2.09203854 |
| 86 | Arterial thrombosis (HP:0004420) | 2.06090750 |
| 87 | Lymphoma (HP:0002665) | 2.02374648 |
| 88 | Gingivitis (HP:0000230) | 2.01569981 |
| 89 | Pulmonary fibrosis (HP:0002206) | 1.97856591 |
| 90 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.97751672 |
| 91 | Supranuclear gaze palsy (HP:0000605) | 1.97719859 |
| 92 | Albinism (HP:0001022) | 1.97526938 |
| 93 | Malnutrition (HP:0004395) | 1.97481615 |
| 94 | Keratitis (HP:0000491) | 1.94331190 |
| 95 | Neuronal loss in central nervous system (HP:0002529) | 1.91229426 |
| 96 | Splenomegaly (HP:0001744) | 1.90439389 |
| 97 | Hypochromic anemia (HP:0001931) | 1.90011313 |
| 98 | Conjunctival telangiectasia (HP:0000524) | 1.88542627 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 1.86889293 |
| 100 | Amaurosis fugax (HP:0100576) | 1.86307766 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K13 | 4.48430129 |
| 2 | RIPK4 | 3.53442061 |
| 3 | MAP3K14 | 2.83671673 |
| 4 | MAP4K1 | 2.70328125 |
| 5 | ARAF | 2.61160437 |
| 6 | PRPF4B | 2.57622864 |
| 7 | TXK | 2.50287152 |
| 8 | IKBKE | 2.32111380 |
| 9 | BLK | 2.24748694 |
| 10 | ERN1 | 2.21864234 |
| 11 | TBK1 | 2.21556878 |
| 12 | TESK2 | 2.21146240 |
| 13 | IRAK4 | 2.06504351 |
| 14 | TYK2 | 1.99628838 |
| 15 | ZAP70 | 1.92621896 |
| 16 | CSK | 1.90442061 |
| 17 | MAP2K3 | 1.86829926 |
| 18 | SIK3 | 1.85990417 |
| 19 | BMPR2 | 1.77812144 |
| 20 | TAOK3 | 1.76933257 |
| 21 | TAOK2 | 1.66899928 |
| 22 | KSR2 | 1.64360461 |
| 23 | IKBKB | 1.62144405 |
| 24 | IRAK3 | 1.60042408 |
| 25 | SYK | 1.59802155 |
| 26 | JAK3 | 1.55729947 |
| 27 | GRK6 | 1.54890373 |
| 28 | BTK | 1.54267974 |
| 29 | MAP3K9 | 1.49515003 |
| 30 | CDK19 | 1.47678081 |
| 31 | MARK3 | 1.45140832 |
| 32 | MAP3K11 | 1.44437988 |
| 33 | MAP3K1 | 1.43311871 |
| 34 | CSF1R | 1.37323078 |
| 35 | MAP3K3 | 1.34279007 |
| 36 | RAF1 | 1.32046070 |
| 37 | TAOK1 | 1.27384801 |
| 38 | MOS | 1.21044606 |
| 39 | SCYL2 | 1.18528293 |
| 40 | FGR | 1.15064484 |
| 41 | MAP3K5 | 1.13847436 |
| 42 | FES | 1.13368820 |
| 43 | LYN | 1.12948072 |
| 44 | PIM1 | 1.10437815 |
| 45 | JAK1 | 1.08791662 |
| 46 | LCK | 1.06436970 |
| 47 | KIT | 1.03098155 |
| 48 | HCK | 1.02975975 |
| 49 | ITK | 1.02431353 |
| 50 | KSR1 | 1.00338306 |
| 51 | MAP3K12 | 0.99953929 |
| 52 | STK10 | 0.98511176 |
| 53 | MATK | 0.98194389 |
| 54 | BRAF | 0.97083042 |
| 55 | GRK7 | 0.95659929 |
| 56 | JAK2 | 0.94654179 |
| 57 | CDK12 | 0.92307238 |
| 58 | PDK1 | 0.91775498 |
| 59 | PIK3CG | 0.88608200 |
| 60 | PIM2 | 0.88228207 |
| 61 | TNK2 | 0.87271063 |
| 62 | TEC | 0.84991346 |
| 63 | CHUK | 0.76648310 |
| 64 | PRKCQ | 0.74013593 |
| 65 | MST4 | 0.72569319 |
| 66 | MAP3K8 | 0.67497783 |
| 67 | IRAK1 | 0.64671659 |
| 68 | STK24 | 0.63414983 |
| 69 | EPHB1 | 0.63183617 |
| 70 | NME2 | 0.57388609 |
| 71 | PDPK1 | 0.56396806 |
| 72 | CLK1 | 0.55711025 |
| 73 | MARK2 | 0.50936393 |
| 74 | PASK | 0.50869617 |
| 75 | SIK2 | 0.48520265 |
| 76 | MAP2K7 | 0.46732445 |
| 77 | TESK1 | 0.46235302 |
| 78 | DYRK1B | 0.42840231 |
| 79 | EPHA3 | 0.42107850 |
| 80 | MAPK11 | 0.41794994 |
| 81 | ACVR1B | 0.41515139 |
| 82 | TRIM28 | 0.39290128 |
| 83 | NEK6 | 0.37436777 |
| 84 | MAPKAPK2 | 0.36775484 |
| 85 | FYN | 0.36485445 |
| 86 | MAP3K4 | 0.35284565 |
| 87 | KDR | 0.35007629 |
| 88 | IRAK2 | 0.33855985 |
| 89 | LRRK2 | 0.32967659 |
| 90 | MAP3K6 | 0.30952606 |
| 91 | AURKA | 0.28502867 |
| 92 | PAK1 | 0.26747922 |
| 93 | CAMKK2 | 0.26666414 |
| 94 | EIF2AK3 | 0.24098569 |
| 95 | CAMKK1 | 0.22707346 |
| 96 | ABL1 | 0.21618404 |
| 97 | MAP3K2 | 0.21141139 |
| 98 | CDK4 | 0.20861380 |
| 99 | MAP2K4 | 0.20585794 |
| 100 | DYRK3 | 0.20330670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.98900901 |
| 2 | Allograft rejection_Homo sapiens_hsa05330 | 2.58048666 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.53779443 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.51036060 |
| 5 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.45708518 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.45476257 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 2.42456162 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.38066234 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.37097811 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.32320384 |
| 11 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.19727750 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.03947023 |
| 13 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.00850866 |
| 14 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.99080287 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.93085479 |
| 16 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.90276916 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.87588408 |
| 18 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.87007753 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85683670 |
| 20 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.85419096 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.84878890 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.80526031 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.80025451 |
| 24 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.75021529 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.70297726 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.65664128 |
| 27 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.58511729 |
| 28 | Asthma_Homo sapiens_hsa05310 | 1.58140655 |
| 29 | Hepatitis B_Homo sapiens_hsa05161 | 1.57355831 |
| 30 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.54973611 |
| 31 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.51136506 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.50476209 |
| 33 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47339648 |
| 34 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.46937104 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.45741586 |
| 36 | Legionellosis_Homo sapiens_hsa05134 | 1.41673205 |
| 37 | Phagosome_Homo sapiens_hsa04145 | 1.38583634 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.36211199 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.30675313 |
| 40 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.28032849 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.24303306 |
| 42 | Lysosome_Homo sapiens_hsa04142 | 1.23695310 |
| 43 | Salmonella infection_Homo sapiens_hsa05132 | 1.20818026 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.19705085 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18884495 |
| 46 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.17665825 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.15985224 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.14571651 |
| 49 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.12390111 |
| 50 | Other glycan degradation_Homo sapiens_hsa00511 | 1.10385790 |
| 51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.08986712 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.08474471 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 1.06785354 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.05868212 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.03344182 |
| 56 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.00928651 |
| 57 | Platelet activation_Homo sapiens_hsa04611 | 0.91688549 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.90076081 |
| 59 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.84906563 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.80926131 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.80414515 |
| 62 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75956544 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.68792409 |
| 64 | Endocytosis_Homo sapiens_hsa04144 | 0.68732303 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65243342 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.64950847 |
| 67 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.63679834 |
| 68 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.62422740 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60989266 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58730153 |
| 71 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.58703209 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.57749223 |
| 73 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57551150 |
| 74 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.49761329 |
| 75 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47628326 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43735539 |
| 77 | Basal transcription factors_Homo sapiens_hsa03022 | 0.42513872 |
| 78 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.40544413 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39282790 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38594362 |
| 81 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37419961 |
| 82 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.36428891 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34559391 |
| 84 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.33658685 |
| 85 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.30588932 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.30249340 |
| 87 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.27371331 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27032757 |
| 89 | Prion diseases_Homo sapiens_hsa05020 | 0.25601807 |
| 90 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24721470 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24118999 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.22107227 |
| 93 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.21619127 |
| 94 | Long-term depression_Homo sapiens_hsa04730 | 0.21041440 |
| 95 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.20465362 |
| 96 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.20369811 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.19933129 |
| 98 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.19305750 |
| 99 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.19184095 |
| 100 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.19156467 |

